Nektar Therapeutics (NKTR) Ovarian Cancer Drug Benefits Women in Study
6/7/2010 7:01:33 AM
Reuters -- About 48 percent of women with advanced ovarian cancer saw sustained benefits from treatment with Nektar Therapeutics' experimental drug NKTR-102 in a mid-stage study, the company said on Sunday.
|